ArticleFrontiers in public health2026
Assessing tuberculosis stigma: a pooled multi-country descriptive analysis of 17 high-burden countries using a standardised tool.
Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Beyond metrics: relational dynamics and impacts of TB community funding.Frontiers in public health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Tuberculosis (TB) stigma continues to impede equitable access to prevention, diagnosis, treatment, and care, undermining efforts to end the epidemic. Despite commitments to eliminate TB stigma in the 2023 United Nations Political Declaration on TB, implementation of evidence-based stigma reduction interventions remains constrained by limited systematic and comparable data. This community-led paper describes findings from 17 national TB stigma assessments conducted using validated stigma measurement scales and guided by the World Health Organization social-ecological model to generate cross-country evidence for action. Across the 17 countries-representing 38% of the estimated global TB burden in 2024-a total of 26,040 individuals participated in the quantitative components. Participants included people with TB (56%,
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.